FDA

Latest Stories

Health and Human Services Secretary Alex M. Azar II said the CDC is wording on a public-service campaign about the vaccine's safety. (Associated Press)

Health officials work to calm fears on COVID-19 vaccines

By Tom Howell Jr. - The Washington Times

President Donald Trump departs behind Health and Human Services Secretary Alex Azar as Azar puts on a face mask to protect against the spread of the coronavirus after a roundtable discussion on the coronavirus outbreak and storm preparedness at Pelican Golf Club in Belleair, Fla., Friday, July 31, 2020. (AP Photo/Patrick Semansky)

Alex Azar, health secretary: Already briefing Biden team on COVID-19

By Tom Howell Jr. - The Washington Times

FILE - In this Nov. 9, 2020, file photo, pedestrians walk past Pfizer world headquarters in New York. Pfizer announced Wednesday, Nov. 18, 2020, more results in its ongoing coronavirus vaccine study that suggest the shots are 95% effective a month after the first dose. (AP Photo/Bebeto Matthews, File)

Pfizer seeking emergency use of its COVID-19 vaccine in U.S.

By Lauran Neergaard - Associated Press

What does emergency use of a COVID-19 vaccine mean? AP Illustration/Peter Hamlin

What does emergency use of a COVID-19 vaccine mean?

By The Associated Press - Associated Press

FILE - In this Thursday Oct. 15, 2020 file photo, A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary. Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. The World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. (Zsolt Czegledi/MTI via AP, File)

FDA gives emergency approval for rheumatoid arthritis drug and remdesivir as COVID-19 treatment

By Shen Wu Tan - The Washington Times

FILE - This Thursday, Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. FDA officials on Tuesday, Nov. 17, 2020, allowed emergency use of the first rapid coronavirus test that can be performed and developed entirely at home. (AP Photo/Jacquelyn Martin, File)

FDA allows 1st rapid virus test that gives results at home

By MATTHEW PERRONE - Associated Press

FILE - In this Nov. 13, 2020, file photo President Donald Trump speaks in the Rose Garden of the White House in Washington. (AP Photo/Evan Vucci, File)

AP FACT CHECK: Trump’s bogus claims about Biden win, vaccine

By HOPE YEN and COLLEEN LONG and LAURAN NEERGAARD - Associated Press

President Donald Trump listens during an event on Operation Warp Speed in the Rose Garden of the White House, Friday, Nov. 13, 2020, in Washington. (AP Photo/Evan Vucci)

AP FACT CHECK: Trump falsehoods on Biden win, vaccine myths

By HOPE YEN and COLLEEN LONG and LAURAN NEERGAARD - Associated Press

FILE - In this Nov. 11, 2020, file photo, medical works operate a testing tent at a COVID-19 mobile testing site in the Brooklyn borough of New York. School systems in several states are giving up on in-person classes, and some governors are reimposing restrictions on bars and restaurants or getting more serious about masks, as the coast-to-coast resurgence of the coronavirus sends deaths, hospitalizations and new infections soaring. (AP Photo/John Minchillo, File)

Trump, still not conceding defeat, trumpets vaccine progress

By ZEKE MILLER and KEVIN FREKING and AAMER MADHANI - Associated Press

In this photo provided by Cincinnati Children’s Hospital Medical Center, clinical research coordinator Tammy Lewis-McCauley administers an injection to Katelyn Evans, a trial participant, as part of the hospital’s clinical trial of Pfizer's COVID-19 vaccine at Cincinnati Children’s Hospital Medical Center on Wednesday, Oct. 14, 2020. (Cincinnati Children’s Hospital Medical Center via AP)

Pfizer: Early look shows COVID-19 vaccine is 90% effective

By Tom Howell Jr. - The Washington Times

In this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer’s disease research in a laboratory at the drugmaker’s headquarters in Cambridge, Mass. On Friday, Nov. 6, 2020, a panel of outside experts will meet to advise the Food and Drug Administration on the drug, called aducanumab from Biogen Inc. and Japan’s Eisai Co. The drug does not cure or reverse Alzheimer’s; the claim is that it modestly slows the rate of decline. (David A. White/Biogen via AP)

FDA panel urges rejection of experimental Alzheimer’s drug

By MARILYNN MARCHIONE and MATTHEW PERRONE - Associated Press

A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, Thursday Oct. 15, 2020. A large study led by the World Health Organization released on Friday, Oct. 16, 2020, suggests that the antiviral drug did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival. (Zsolt Czegledi/MTI via AP)

Remdesivir is first coronavirus drug approved by FDA

By Marilynn Marchione - Associated Press

This Thursday, Nov. 2, 2017 photo shows tablets of ibuprofen in New York. On Thursday, Oct. 15, 2020, the Food and Drug Administration said that pregnant women should avoid a group of common pain relievers including Advil and Aleve for the last four months of pregnancy, expanding the warning from three months. (AP Photo/Patrick Sison)

FDA extends pregnancy warning for common pain relievers

By MATTHEW PERRONE - Associated Press

This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. (AP Photo/Jacquelyn Martin, File)

White House nixes updated FDA guidelines on vaccine approval

By Zeke Miller and Matthew Perrone - Associated Press

In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. A letter from federal health officials instructing states to be ready to begin distributing a vaccine by Nov. 1 — two days before the election — has met, not with exhilaration, but with suspicion among public health experts and others. (AP Photo/Hans Pennink, File)

Fed gov’t begins to detail a ‘highly controlled’ vaccine distribution plan

By Tom Howell Jr. - The Washington Times

In this undated photo provided by Outdoor Research in September 2020, a worker handles filter material for face masks in Seattle. A key challenge for N95 mask manufacturers racing to meet spiking demand is scarcity of meltblown textile. (Gerardo Villalobos/Outdoor Research via AP)

Scarcity of raw material still squeezes N95 mask makers

By MARTHA MENDOZA, JULIET LINDERMAN and THOMAS PEIPERT AND IRENA HWANG - Associated Press

In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. A letter from federal health officials instructing states to be ready to begin distributing a vaccine by Nov. 1 — two days before the election — has met, not with exhilaration, but with suspicion among public health experts and others. (AP Photo/Hans Pennink, File)

Americans fear coronavirus vaccine will be based on politics over safety

By Tom Howell Jr. - The Washington Times

In this undated photo provided by Outdoor Research in September 2020, a worker handles filter material for face masks in Seattle. A key challenge for N95 mask manufacturers racing to meet spiking demand is scarcity of meltblown textile. (Gerardo Villalobos/Outdoor Research via AP)

Scarcity of key material squeezes medical mask manufacturing

By MARTHA MENDOZA, JULIET LINDERMAN and THOMAS PEIPERT and IRENA HWANG - Associated Press

FILE - This July 18, 2020, file photo, shows the AstraZeneca offices in Cambridge, England. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. The company said the study will involve up to 30,000 adults from various racial, ethnic and geographic groups. (AP Photo/Alastair Grant, File)

Vaccine by Nov. 3? Halted study explains just how unlikely

By LAURAN NEERGAARD - Associated Press

In this Monday, July 27, 2020, file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Tuesday, Sept. 8, 2020, the top executives of nine drugmakers likely to produce the first vaccines against the new coronavirus said that they will stick to the highest ethical and scientific standards in testing and manufacturing and will make the well-being of those getting vaccinated their top priority. (AP Photo/Hans Pennink)

Nine drug CEOs sign safety pledge on COVID-19 vaccine

By Tom Howell Jr. - The Washington Times